BioCentury
ARTICLE | Politics & Policy

Saunders says Allergan will limit price increases

September 6, 2016 7:00 AM UTC

In a blog post, Allergan plc (NYSE:AGN) President and CEO Brent Saunders pledged to price the company's products "in a way that is commensurate with, or lower than, the value they create," and to limit price hikes for Allergan's branded therapeutics to single-digit percentage increases no more than once per year.

Saunders, a PhRMA board member, wrote that while patients understand that drug research requires significant investment, companies with "aggressive or predatory" price strategies have violated a social contract with patients. ...